|
1
|
Verma S and Kellum JA: Defining acute
kidney injury. Crit Care Clin. 37:251–266. 2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bidani A and Churchill PC: Acute renal
failure. Dis Mon. 35:57–132. 1989.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Kulvichit W, Kellum JA and Srisawat N:
Biomarkers in acute kidney injury. Crit Care Clin. 37:385–398.
2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Yang L, Xing G, Wang L, Wu Y, Li S, Xu G,
He Q, Chen J, Chen M, Liu X, et al: Acute kidney injury in China: A
cross-sectional survey. Lancet. 386:1465–1471. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Hilton R: Acute renal failure. BMJ.
333:786–790. 2006.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Han SJ and Lee HT: Mechanisms and
therapeutic targets of ischemic acute kidney injury. Kidney Res
Clin Pract. 38:427–440. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Jan R and Chaudhry GE: Understanding
apoptosis and apoptotic pathways targeted cancer therapeutics. Adv
Pharm Bull. 9:205–218. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Chatterjee PK, Todorovic Z, Sivarajah A,
Mota-Filipe H, Brown PA, Stewart KN, Cuzzocrea S and Thiemermann C:
Differential effects of caspase inhibitors on the renal dysfunction
and injury caused by ischemia-reperfusion of the rat kidney. Eur J
Pharmacol. 503:173–183. 2004.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Xiao Z, Shan J, Li C, Luo L, Lu J, Li S,
Long D and Li Y: Mechanisms of cyclosporine-induced renal cell
apoptosis: A systematic review. Am J Nephrol. 37:30–40.
2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wu TJ, Hsieh YJ, Lu CW, Lee CJ and Hsu BG:
Linagliptin protects against endotoxin-induced acute kidney injury
in rats by decreasing inflammatory cytokines and reactive oxygen
species. Int J Mol Sci. 22(11190)2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Vomund S, Schäfer A, Parnham MJ, Brüne B
and von Knethen A: Nrf2, the master regulator of anti-oxidative
responses. Int J Mol Sci. 18(2772)2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Abdo S, Zhang SL and Chan JS: Reactive
oxygen species and nuclear factor erythroid 2-related factor 2
activation in diabetic nephropathy: A hidden target. J Diabetes
Metab 6: 10.4172/2155-6156.1000547, 2015.
|
|
13
|
Ishii T, Itoh K, Takahashi S, Sato H,
Yanagawa T, Katoh Y, Bannai S and Yamamoto M: Transcription factor
Nrf2 coordinately regulates a group of oxidative stress-inducible
genes in macrophages. J Biol Chem. 275:16023–16029. 2000.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bolignano D, Donato V, Coppolino G, Campo
S, Buemi A, Lacquaniti A and Buemi M: Neutrophil
gelatinase-associated lipocalin (NGAL) as a marker of kidney
damage. Am J Kidney Dis. 52:595–605. 2008.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Rhee H, Shin N, Shin MJ, Yang BY, Kim IY,
Song SH, Lee DW, Lee SB, Kwak IS and Seong EY: High serum and urine
neutrophil gelatinase-associated lipocalin levels are independent
predictors of renal progression in patients with immunoglobulin A
nephropathy. Korean J Intern Med. 30:354–361. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Albert C, Zapf A, Haase M, Röver C,
Pickering JW, Albert A, Bellomo R, Breidthardt T, Camou F, Chen Z,
et al: Neutrophil gelatinase-associated lipocalin measured on
clinical laboratory platforms for the prediction of acute kidney
injury and the associated need for dialysis therapy: A systematic
review and meta-analysis. Am J Kidney Dis. 76:826–841.e1.
2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Naunova-Timovska S, Cekovska S, Sahpazova
E and Tasić V: Neutrophil gelatinase-associated lipocalin as an
early biomarker of acute kidney injury in newborns. Acta Clin
Croat. 59:55–62. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Albeladi FI and Algethamy HM: Urinary
neutrophil gelatinase-associated lipocalin as a predictor of acute
kidney injury, severe kidney injury, and the need for renal
replacement therapy in the intensive care unit. Nephron Extra.
7:62–77. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Jose RL, Damayanathi D, Unnikrishnan KP
and Suneel PR: A comparison of sevoflurane versus
sevoflurane-propofol combination on renal function in patients
undergoing valvular heart surgery-A prospective randomized
controlled pilot study. Ann Card Anaesth. 24:172–177.
2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Li H, Weng Y, Yuan S, Liu W, Yu H and Yu
W: Effect of sevoflurane and propofol on acute kidney injury in
pediatric living donor liver transplantation. Ann Transl Med.
7(340)2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ministry of Science and Technology of the
PRC. Available from: https://www.puh3.net.cn/images/dwsyzx/zc/2020/5/30/227A82A9E2B44976986A1EB84BB39836.pdf.
|
|
22
|
Zhang S, Xin H, Li Y, Zhang D, Shi J, Yang
J and Chen X: Skimmin, a coumarin from hydrangea paniculata, slows
down the progression of membranous glomerulonephritis by
anti-inflammatory effects and inhibiting immune complex deposition.
Evid Based Complement Alternat Med. 2013(819296)2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhang S, Ma J, Sheng L, Zhang D, Chen X,
Yang J and Wang D: Total coumarins from hydrangea paniculata show
renal protective effects in lipopolysaccharide-induced acute kidney
injury via anti-inflammatory and antioxidant activities. Front
Pharmacol. 8(872)2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Han SJ, Kim JH, Kim JI and Park KM:
Inhibition of microtubule dynamics impedes repair of kidney
ischemia/reperfusion injury and increases fibrosis. Sci Rep.
6(27775)2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Gonul Y, Ozsoy M, Kocak A, Ozkececi ZT,
Karavelioglu A, Bozkurt MF, Cartilli O, Keles I, Kocak H and Celik
S: Antioxidant, antiapoptotic and inflammatory effects of
interleukin-18 binding protein on kidney damage induced by hepatic
ischemia reperfusion. Am J Med Sci. 351:607–615. 2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Linas SL, Whittenburg D and Repine JE:
Role of xanthine oxidase in ischemia/reperfusion injury. Am J
Physiol. 258:F711–F716. 1990.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Granger DN and Kvietys PR: Reperfusion
injury and reactive oxygen species: The evolution of a concept.
Redox Biol. 6:524–551. 2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Granger DN, Rutili G and McCord JM:
Superoxide radicals in feline intestinal ischemia.
Gastroenterology. 81:22–29. 1981.PubMed/NCBI
|
|
29
|
Nuñez G, Benedict MA, Hu Y and Inohara N:
Caspases: The proteases of the apoptotic pathway. Oncogene.
17:3237–3245. 1998.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Ighodaro OM and Akinloye OA: First line
defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and
glutathione peroxidase (GPX): Their fundamental role in the entire
antioxidant defence grid. Alex J Med. 54:287–293. 2018.
|
|
31
|
Silva-Islas CA and Maldonado PD: Canonical
and non-canonical mechanisms of Nrf2 activation. Pharmacol Res.
134:92–99. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Loboda A, Damulewicz M, Pyza E, Jozkowicz
A and Dulak J: Role of Nrf2/HO-1 system in development, oxidative
stress response and diseases: An evolutionarily conserved
mechanism. Cell Mol Life Sci. 73:3221–3247. 2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ruan H, Luo J, Wang L, Wang J, Wang Z and
Zhang J: Sika deer antler protein against acetaminophen-induced
nephrotoxicity by activating Nrf2 and inhibition FoxO1 via PI3K/Akt
signaling. Int J Biol Macromol. 141:961–987. 2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Meng XM, Nikolic-Paterson DJ and Lan HY:
Inflammatory processes in renal fibrosis. Nat Rev Nephrol.
10:493–503. 2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Sun L and Kanwar YS: Relevance of TNF-α in
the context of other inflammatory cytokines in the progression of
diabetic nephropathy. Kidney Int. 88:662–665. 2015.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Griffin GK, Newton G, Tarrio ML, Bu DX,
Maganto-Garcia E, Azcutia V, Alcaide P, Grabie N, Luscinskas FW,
Croce KJ and Lichtman AH: IL-17 and TNF-α sustain neutrophil
recruitment during inflammation through synergistic effects on
endothelial activation. J Immunol. 188:6287–6299. 2012.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Tanaka T, Narazaki M and Kishimoto T: IL-6
in inflammation, immunity, and disease. Cold Spring Harb Perspect
Biol. 6(a016295)2014.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Neag MA, Mitre AO, Catinean A and Mitre
CI: An overview on the mechanisms of neuroprotection and
neurotoxicity of isoflurane and sevoflurane in experimental
studies. Brain Res Bull. 165:281–289. 2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Fang FQ, Sun JH, Wu QL, Feng LY, Fan YX,
Ye JX, Gao W, He GL and Wang WJ: Protective effect of sevoflurane
on vascular endothelial glycocalyx in patients undergoing heart
valve surgery: A randomised controlled trial. Eur J Anaesthesiol.
38:477–486. 2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Sen Z, Jie M, Jingzhi Y, Dongjie W,
Dongming Z and Xiaoguang C: Total coumarins from hydrangea
paniculata protect against cisplatin-induced acute kidney damage in
mice by suppressing renal inflammation and apoptosis. Evid Based
Complement Alternat Med. 2017(5350161)2017.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Chung CH, Fan J, Lee EY, Kang JS, Lee SJ,
Pyagay PE, Khoury CC, Yeo TK, Khayat MF, Wang A and Chen S: Effects
of tumor necrosis factor-α on podocyte expression of monocyte
chemoattractant protein-1 and in diabetic nephropathy. Nephron
Extra. 5:1–18. 2015.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Haller H, Bertram A, Nadrowitz F and Menne
J: Monocyte chemoattractant protein-1 and the kidney. Curr Opin
Nephrol Hypertens. 25:42–49. 2016.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Voll RE, Herrmann M, Roth EA, Stach C,
Kalden JR and Girkontaite I: Immunosuppressive effects of apoptotic
cells. Nature. 390:350–351. 1997.PubMed/NCBI View
Article : Google Scholar
|
|
44
|
Fadok VA, Bratton DL, Konowal A, Freed PW,
Westcott JY and Henson PM: Macrophages that have ingested apoptotic
cells in vitro inhibit proinflammatory cytokine production through
autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J
Clin Invest. 101:890–898. 1998.PubMed/NCBI View Article : Google Scholar
|
